Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

OMKAR PHARMACHEM vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    OMKAR PHARMACHEM DR. REDDYS LAB OMKAR PHARMACHEM/
DR. REDDYS LAB
 
P/E (TTM) x 116.1 24.2 479.7% View Chart
P/BV x 2.5 3.7 66.7% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 OMKAR PHARMACHEM   DR. REDDYS LAB
EQUITY SHARE DATA
    OMKAR PHARMACHEM
Mar-21
DR. REDDYS LAB
Mar-22
OMKAR PHARMACHEM/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs215,614 0.4%   
Low Rs163,655 0.4%   
Sales per share (Unadj.) Rs0.31,294.6 0.0%  
Earnings per share (Unadj.) Rs0.2126.9 0.2%  
Cash flow per share (Unadj.) Rs0.2196.9 0.1%  
Dividends per share (Unadj.) Rs030.00 0.0%  
Avg Dividend yield %00.6 0.0%  
Book value per share (Unadj.) Rs8.61,145.8 0.8%  
Shares outstanding (eoy) m10.08166.43 6.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x68.43.6 1,909.4%   
Avg P/E ratio x83.336.5 228.2%  
P/CF ratio (eoy) x82.923.5 352.5%  
Price / Book Value ratio x2.14.0 52.7%  
Dividend payout %023.6 0.0%   
Avg Mkt Cap Rs m185771,272 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m138,858 0.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3215,452 0.0%  
Other income Rs m04,847 0.0%   
Total revenues Rs m3220,299 0.0%   
Gross profit Rs m037,674 0.0%  
Depreciation Rs m011,652 0.0%   
Interest Rs m1958 0.1%   
Profit before tax Rs m029,911 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-38,789 -0.0%   
Profit after tax Rs m221,122 0.0%  
Gross profit margin %8.117.5 46.2%  
Effective tax rate %714.729.4 2,432.4%   
Net profit margin %82.09.8 836.4%  
BALANCE SHEET DATA
Current assets Rs m1177,880 0.0%   
Current liabilities Rs m1097,658 0.0%   
Net working cap to sales %-332.137.2 -891.9%  
Current ratio x0.11.8 4.0%  
Inventory Days Days12,57256 22,557.3%  
Debtors Days Days365113 322.7%  
Net fixed assets Rs m93106,819 0.1%   
Share capital Rs m101832 12.1%   
"Free" reserves Rs m-14189,859 -0.0%   
Net worth Rs m87190,691 0.0%   
Long term debt Rs m05,746 0.0%   
Total assets Rs m94284,699 0.0%  
Interest coverage x0.432.2 1.1%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x00.8 3.8%   
Return on assets %3.07.8 38.3%  
Return on equity %2.611.1 23.1%  
Return on capital %0.215.7 1.5%  
Exports to sales %047.1 0.0%   
Imports to sales %018.8 0.0%   
Exports (fob) Rs mNA101,544 0.0%   
Imports (cif) Rs mNA40,401 0.0%   
Fx inflow Rs m0101,544 0.0%   
Fx outflow Rs m040,401 0.0%   
Net fx Rs m061,143 0.0%   
CASH FLOW
From Operations Rs m028,108 0.0%  
From Investments Rs mNA-26,387 0.0%  
From Financial Activity Rs mNA-2,422 0.0%  
Net Cashflow Rs m032 0.1%  

Share Holding

Indian Promoters % 0.0 26.7 0.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 51.1 -  
FIIs % 0.0 25.9 -  
ADR/GDR % 0.0 10.4 -  
Free float % 100.0 62.9 158.9%  
Shareholders   3,561 255,300 1.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare OMKAR PHARMACHEM With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    ZYDUS LIFESCIENCES    



Today's Market

Sensex Zooms 130 Points, Nifty Ends Above 17,600; Financial and IT Stocks Rally(Closing)

Indian benchmark indices ended on a positive note amid a highly volatile session. This was on the back of metal stocks along with banking and financials.